[{"address1": "5959 Horton Street", "address2": "7th Floor", "city": "EmeryVille", "state": "CA", "zip": "94608", "country": "United States", "phone": "510 871 4880", "website": "https://metagenomi.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medicines using genome editing technologies; and a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited TCR-based therapeutic products exclusively in the field of treatment, prevention, or diagnosis of any human cancer. Metagenomi, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.", "fullTimeEmployees": 202, "companyOfficers": [{"maxAge": 1, "name": "Ms. Pamela M. Wapnick M.B.A.", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 581813, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph  Knowles M.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew L. Wein J.D.", "age": 53, "title": "Senior VP, Head of Legal, Compliance Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Brooks Ph.D.", "age": 58, "title": "Head of Preclinical", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher  Brown", "age": 35, "title": "Head of Discovery", "yearBorn": 1989, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.7, "open": 1.65, "dayLow": 1.65, "dayHigh": 1.7993, "regularMarketPreviousClose": 1.7, "regularMarketOpen": 1.65, "regularMarketDayLow": 1.65, "regularMarketDayHigh": 1.7993, "payoutRatio": 0.0, "forwardPE": -0.59999996, "volume": 364357, "regularMarketVolume": 364357, "averageVolume": 617612, "averageVolume10days": 485850, "averageDailyVolume10Day": 485850, "bid": 1.71, "ask": 1.81, "bidSize": 1, "askSize": 1, "marketCap": 65331348, "fiftyTwoWeekLow": 1.23, "fiftyTwoWeekHigh": 4.92, "allTimeHigh": 12.74, "allTimeLow": 1.23, "priceToSalesTrailing12Months": 2.113394, "fiftyDayAverage": 2.4286, "twoHundredDayAverage": 2.001525, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": -2.8705702, "floatShares": 26927689, "sharesOutstanding": 37546751, "sharesShort": 1402015, "sharesShortPriorMonth": 1490834, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0374, "heldPercentInsiders": 0.2809, "heldPercentInstitutions": 0.17904, "shortRatio": 1.53, "shortPercentOfFloat": 0.0513, "impliedSharesOutstanding": 37533136, "bookValue": 6.276, "priceToBook": 0.27724665, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -88738000, "trailingEps": -2.39, "forwardEps": -2.9, "52WeekChange": -0.028571427, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 1.74, "targetHighPrice": 12.0, "targetLowPrice": 7.0, "targetMeanPrice": 8.66667, "targetMedianPrice": 7.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "ebitda": -86803000, "totalRevenue": 30913000, "debtToEquity": 21.953, "revenuePerShare": 0.831, "grossProfits": -78266000, "revenueGrowth": -0.248, "grossMargins": -2.53182, "ebitdaMargins": -2.80798, "operatingMargins": -2.6376002, "financialCurrency": "USD", "symbol": "MGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1763167960, "regularMarketTime": 1763154001, "exchange": "NMS", "messageBoardId": "finmb_633445224", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-02-09", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1707489000000, "postMarketChangePercent": 5.672416, "postMarketPrice": 1.8387, "postMarketChange": 0.09870005, "regularMarketChange": 0.04, "regularMarketDayRange": "1.65 - 1.7993", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 617612, "fiftyTwoWeekLowChange": 0.51, "fiftyTwoWeekLowChangePercent": 0.41463414, "fiftyTwoWeekRange": "1.23 - 4.92", "fiftyTwoWeekHighChange": -3.18, "fiftyTwoWeekHighChangePercent": -0.64634144, "fiftyTwoWeekChangePercent": -2.8571427, "earningsTimestampStart": 1755115200, "earningsTimestampEnd": 1755115200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.39, "epsForward": -2.9, "epsCurrentYear": -2.27, "priceEpsCurrentYear": -0.76651984, "fiftyDayAverageChange": -0.68860006, "fiftyDayAverageChangePercent": -0.28353786, "twoHundredDayAverageChange": -0.26152492, "twoHundredDayAverageChangePercent": -0.13066283, "sourceInterval": 15, "marketState": "CLOSED", "regularMarketChangePercent": 2.35294, "regularMarketPrice": 1.74, "shortName": "Metagenomi, Inc.", "longName": "Metagenomi, Inc.", "displayName": "Metagenomi", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]